Home > Qtrly Results > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Quarterly Results Analysis [Sep2023]

COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Quarterly Results

Standalone Sep2023
UnAudited
Jun2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Dec2021
UnAudited
Sep2021
UnAudited
Jun2021
UnAudited
Revenues ₹0 Cr ₹0 Cr ₹0 Cr ₹26 Cr ₹10 Cr ₹17 Cr ₹25 Cr ₹14 Cr
Expenses ₹5 Cr ₹4 Cr ₹5 Cr ₹29 Cr ₹15 Cr ₹16 Cr ₹28 Cr ₹13 Cr
Operating Income ₹-5 Cr ₹-4 Cr ₹-5 Cr ₹-3 Cr ₹-5 Cr ₹1 Cr ₹-3 Cr ₹1 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹-7 Cr ₹-6 Cr ₹-6 Cr ₹-4 Cr ₹-6 Cr ₹0 Cr ₹-5 Cr ₹0 Cr
Profit After Tax ₹-5 Cr ₹-5 Cr ₹-5 Cr ₹-3 Cr ₹-5 Cr ₹0 Cr ₹-9 Cr ₹2 Cr
EPS ₹-1.14 ₹-1.06 ₹-1.08 ₹-0.71 ₹-1.16 ₹-0.08 ₹-2.17 ₹0.45
Industry Peers & Returns1W1M1Y
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 9.1% -9.8% 22.4%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Quarterly Revenues

Revenues
Q-o-Q

0 %

Y-o-Y

-100.00 %

Quarters Revenues % Change
Sep2023 ₹0 Cr
0
Jun2023 ₹0 Cr
0
Dec2022 ₹0 Cr
-100.00
Sep2022 ₹26 Cr
152.70
Jun2022 ₹10 Cr
-39.88
Dec2021 ₹17 Cr
-29.44
Sep2021 ₹25 Cr
73.77
Jun2021 ₹14 Cr -

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Quarterly Operating Profit

Operating Profit
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Profit % Change
Sep2023 ₹-5 Cr
Negative
Jun2023 ₹-4 Cr
Negative
Dec2022 ₹-5 Cr
Negative
Sep2022 ₹-3 Cr
Negative
Jun2022 ₹-5 Cr
Negative
Dec2021 ₹1 Cr
Positive
Sep2021 ₹-3 Cr
Negative
Jun2021 ₹1 Cr -
Operating Margins
Q-o-Q

0

Y-o-Y

100.00 %

Quarters Operating Margin% % Change
Sep2023 0%
0
Jun2023 0%
0
Dec2022 0%
100.00
Sep2022 -9.44%
Negative
Jun2022 -46.09%
Negative
Dec2021 5.82%
Positive
Sep2021 -14.13%
Negative
Jun2021 7.31% -

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Sep2023 ₹-5 Cr
Negative
Jun2023 ₹-5 Cr
Negative
Dec2022 ₹-5 Cr
Negative
Sep2022 ₹-3 Cr
Negative
Jun2022 ₹-5 Cr
Negative
Dec2021 ₹0 Cr
Negative
Sep2021 ₹-9 Cr
Negative
Jun2021 ₹2 Cr -
PAT Margins
Q-o-Q

0

Y-o-Y

100.00 %

Quarters PAT Margin(%) % Change
Sep2023 0 %
0
Jun2023 0 %
0
Dec2022 0 %
100.00
Sep2022 -11.64 %
Negative
Jun2022 -47.68 %
Negative
Dec2021 -1.9 %
Negative
Sep2021 -37.89 %
Negative
Jun2021 13.56 % -

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Sep2023 ₹-1.14
Negative
Jun2023 ₹-1.06
Negative
Dec2022 ₹-1.08
Negative
Sep2022 ₹-0.71
Negative
Jun2022 ₹-1.16
Negative
Dec2021 ₹-0.08
Negative
Sep2021 ₹-2.17
Negative
Jun2021 ₹0.45 -

You may also like the below Video Courses